Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-22-012376
Filing Date
2022-03-25
Accepted
2022-03-25 19:33:28
Documents
1
Period of Report
2021-09-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4085
  Complete submission text file 0000899243-22-012376.txt   5661
Mailing Address C/O OPTIMER PHARMACEUTICALS, INC 101 HUDSON STREET SAN DIEGO CA 07302
Business Address
Webster Stephen W (Reporting) CIK: 0001438421 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39856 | Film No.: 22772908

Mailing Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 520 CAMBRIDGE MA 02142 617-410-4650
Cullinan Oncology, Inc. (Issuer) CIK: 0001789972 (see all company filings)

EIN.: 813867811 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)